A comparison of the impact of anti-IL5/5r therapies in allergic versus non-allergic patients with severe eosinophilic asthma in a real-life setting
Anti-IL5/IL5R reduced the need for OCS and improved asthma control, regardless of allergic status. Fungal allergy led to lower ACT scores and higher exacerbations than other allergens; both groups improved with anti-IL5/ILR.
Authors
- Inés Fernández-Concha (ORCID: https://orcid.org/0009-0001-4555-2648)
- Santiago Quirce (ORCID: https://orcid.org/0000-0001-8086-0921)
- Javier Domínguez‐Ortega (ORCID: https://orcid.org/0000-0002-5397-2327)
- Daniel Laorden (ORCID: https://orcid.org/0000-0001-9054-5925)
- Mónica Colque-Bayona (ORCID: https://orcid.org/0000-0003-1534-5573)
- Tatiana Navarro-Cascales (ORCID: https://orcid.org/0000-0002-8621-8486)
Institutions
- Hospital Universitario La Paz (ES)
- Hospital La Paz Institute for Health Research (ES)
- Centro de Investigación Biomédica en Red (ES)
Publication Details
- Journal
- Journal of Asthma
- Published
- 2024-09-05
- DOI
- https://doi.org/10.1080/02770903.2024.2400607
- Citations
- 2
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.65